Dietary polyphenols for treatment of Alzheimer's disease- future research and development

Current Pharmaceutical Biotechnology

Volumn 15, Issue 4, 2014, Pages 330-342

  Malar, D Sheeja ^a   Devi, K Pandima ^a  

^a ALAGAPPA UNIVERSITY   (India)

Author keywords

Acetylcholine; Alzheimer's disease; Amyloid beta; Beta secretase; Neurofibrillary tangles; Neuroinflammation; Polyphenols; Sirtuins

Indexed keywords

ACETYLCHOLINESTERASE; AMINE OXIDASE (FLAVIN CONTAINING); AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; APIGENIN; ARACHIDONATE 5 LIPOXYGENASE; BETA SECRETASE 1; BRAIN DERIVED NEUROTROPHIC FACTOR; CATECHIN; CURCUMIN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DAIDZEIN; ESTROGEN; FERULIC ACID; FISETIN; FREE RADICAL; GENISTEIN; GLUTAMIC ACID; GLYCETIN; ISOFLAVONE; NEUROTRANSMITTER; NUTRACEUTICAL; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PHOSPHOPROTEIN PHOSPHATASE 2A; POLYPHENOL; RESVERATROL; SIRTUIN 1; TAU PROTEIN; TRANSCRIPTION FACTOR FKHRL1; UNCLASSIFIED DRUG; UNINDEXED DRUG; COUMARIC ACID; FLAVONOID; STILBENE DERIVATIVE; SCAVENGER;

ALZHEIMER DISEASE; ANTIOXIDANT ACTIVITY; ARTICLE; CALCIUM CELL LEVEL; CLINICAL TRIAL (TOPIC); COGNITIVE DEFECT; DIETARY INTAKE; DRUG TARGETING; ENZYME INHIBITION; GENE ACTIVATION; GENE EXPRESSION; HUMAN; NERVE CELL PLASTICITY; NERVOUS SYSTEM INFLAMMATION; NEUROPROTECTION; NONHUMAN; PHASE 3 CLINICAL TRIAL (TOPIC); PHOSPHORYLATION; PROTEIN AGGREGATION; SIGNAL TRANSDUCTION; TEA; ANIMAL; DIET; DIET THERAPY; METABOLISM; RESEARCH; ANTIBACTERIAL ACTIVITY; ENZYME ACTIVITY; MULTIDRUG RESISTANCE; OXIDATIVE STRESS; PLANT; PROTEIN SYNTHESIS;

ALZHEIMER DISEASE; ANIMALS; COUMARIC ACIDS; CURCUMIN; DIET; FLAVONOIDS; HUMANS; RESEARCH; STILBENES;

EID: 84907361344     PISSN: 13892010     EISSN: 18734316     Source Type: Journal    
DOI: 10.2174/1389201015666140813122703     Document Type: Article

References (182)

1. Kandale, V.V.; Mujawar, S.N.; Welasly, P.J; Nimbalkar J.M. Development of integrated database of Neurodegenerative Diseases (IDND). Rev. Res., 2013, 2(9). 6
2. George-Carey R.; Adeloye, D.; Chan, K.Y.; Paul, A.; Kolčić, I.; Campbell, H.; Rudan, I. An estimate of the prevalence of dementia in Africa: A systematic analysis. J. Glob. Health, 2012, 2(2), 020401.
3. Crews, L.; Masliah, E. Molecular Mechanisms of Neurodegeneration in Alzheimer's Disease. Hum. Mol. Genet., 2010, 19(R1), R12-R20.
4. Brookmeyer, R.; Johnson, E.; Ziegler-Graham, K.; Arrighi, H.M. Forecasting the global burden of Alzheimer's disease. Alzheimer's Dementia, 2007, 3, 186-191.
5. Hebert, L.E.; Scherr, P.A.; Beckeff, L.A. Age-specific incidence of Alzheimer's Disease in a community population. JAMA, 1995, 273, 1354-1359.
6. Onor, M.L.; Trevisiol, M.; Aguglia, E. Rivastigmine in the treatment of Alzheimer's disease: an update. Clin. Interv. Aging, 2007, 2(1), 17-32.
7. Lam, B.; Hollingdrake, E.; Kennedy, J.L.; Black, S.E.; Masellis, M. Cholinesterase inhibitors in Alzheimer's disease and Lewy body spectrum disorders: The emerging pharmacogenetic story. Hum. Genomics, 2009, 4(2), 91-106.
8. Podtelezhnikov, A.A.; Tanis, K.Q.; Nebozhyn, M.; Ray, W.J.; Stone, D.J.; Loboda, A.P. Molecular insights into the pathogenesis of Alzheimer's disease and its relationship to normal aging. PLoS One, 2011, 6(12), e29610.
9. Dong, S.; Duan, Y.; Hu, Y.; Zhao, Z. Advances in the pathogenesis of Alzheimer's disease: a re-evaluation of amyloid cascade hypothesis. Transl. Neurodegener., 2012, 1(1), 18.
10. Kwak, Y.D; Wang, R.; Li, J.J.; Zhang, Y.W.; Xu, H.; Liao, F.F. Differential regulation of BACE1 expression by oxidative and nitrosative signals. Mol. Neurodegener., 2011, 6, 17.
11. Chami, L.; Checler, F. BACE1 is at the crossroad of a toxic vicious cycle involving cellular stress and β-amyloid production in Alzheimer's disease. Mol. Neurodegener., 2012, 7, 52.
12. Prasansuklab, A.; Tencomnao, T. Amyloidosis in Alzheimer's Disease: The toxicity of amyloid beta (aβ), mechanisms of its accumulation and implications of medicinal plants for therapy. Evid. Based Complement. Alternat. Med., 2013, 2013.
13. LaFerla, F.M.; Green, K.N.; Oddo, S. Intracellular amyloid-β in Alzheimer's disease. Nat. Rev. Neurosci., 2007, 8(7), 499-509.
14. Sofola, O.; Kerr, F.; Rogers, I.; Killick, R.; Augustin, H.; Gandy, C.; Allen, M.J.; Hardy, J.; Lovestone, S.; Partridge, L. Inhibition of GSK-3 ameliorates Abeta pathology in an adult-onset Drosophila model of Alzheimer's disease. PLoS Genet., 2010, 6(9), e1001087.
15. Kosik, K.S. The molecular and cellular biology of tau. Brain Pathol., 1993, 3(1), 39-43.
16. Iqbal, K.; Grundke-Iqbal, I. Alzheimer neurofibrillary degeneration: significance, etiopathogenesis, therapeutics and prevention. J. Cell Mol. Med., 2008, 12(1), 38-55.
17. Tseng, B.P.; Green, K.N.; Chan, J.L.; Blurton-Jones, M.; LaFerla, F.M. Abeta inhibits the proteasome and enhances amyloid and tau accumulation. Neurobiol. Aging, 2008, 29(11), 1607-1618.
18. Hensley, K. Neuroinflammation in Alzheimer's disease: mechanisms, pathologic consequences, and potential for therapeutic manipulation. J. Alzheimers. Dis., 2010, 21(1), 1-14.
19. Abbas, N.; Bednar, I.; Mix, E.; Marie, S.; Paterson, D.; Ljungberg, A.; Morris, C.; Winblad, B.; Nordberg, A.; Zhu, J. Up-regulation of the inflammatory cytokines IFN-gamma and IL-12 and downregulation of IL-4 in cerebral cortex regions of APP(SWE) transgenic mice. J. Neuroimmunol., 2002, 126(1-2), 50-57.
20. Lindberg, C.; Hjorth, E.; Post, C.; Winblad, B.; Schultzberg, M. Cytokine production by a human microglial cell line: Effects of ßamyloid and α-melanocyte-stimulating hormone. Neurotox Res., 2005, 8(3-4), 267-276.
21. Mohandas, E.; Rajmohan, V.; Raghunath, B. Neurobiology of Alzheimer's disease. Indian. J. Psychiatry., 2009, 51(1), 55-61.
22. Tabet, N. Acetylcholinesterase inhibitors for Alzheimer's disease: anti-inflammatories in acetylcholine clothing! Age Ageing, 2006, 35(4), 336-338.
23. Parsons, C.G.; Stöffler, A.; Danysz, W. Memantine: A NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutamatergic system--too little activation is bad, too much is even worse. Neuropharmacology, 2007, 53(6), 699-723.
24. Yan, Q.; Zhang J.; Liu, H.; Babu-Khan, S.; Vassar R.; Biere, A.L.; Citron, M.; Landreth, G. Anti-inflammatory drug therapy alters beta-amyloid processing and deposition in an animal model of Alzheimer's disease. J. Neurosci., 2003, 23(20), 7504-7509.
25. Rafii, M.; Aisen, P.S. Recent developments in Alzheimer's disease therapeutics. BMC Medicine, 2009, 7, 7.
26. Beckman, C.H. Phenolic-storing cells: keys to programmed cell death and periderm formation in wilt disease resistance and in general defence responses in plants? Physiol. Mol. Plant Pathol., 2000, 57, 101-110.
27. Hollman, P.C.; Cassidy, A,; Comte, B.; Heinonen, M.; Richelle, M.; Richling, E.; Serafini, M.; Scalbert, A.; Sies, H.; Vidry, S. The biological relevance of direct antioxidant effects of polyphenols for cardiovascular health in humans is not established. J. Nutr., 2011, 141(5), 989S-1009S.
28. Pandey, K.B.; Rizvi, S.I. Plant polyphenols as dietary antioxidants in human health and disease. Oxid. Med. Cell Longev., 2009, 2(5), 270-278.
29. Dai, Q.; Borenstein, A.R.; Wu, Y.; Jackson, J.C.; Larson, E.B. Fruit and vegetable juices and Alzheimer's disease: The Kame project. Am. J. Med., 2006, 119, 751-759.
30. Kuriyama, S.; Hozawa, A.; Ohmori, K.; Shimazu, T.; Matsui, T.; Ebihara, S. Green tea consumption and cognitive function: A crosssectional study from the Tsurugaya Project. Am. J. Clin. Nutr. 2006, 83, 355-361.
31. Scarmeas, N.; Stern, Y.; Tang, M.X.; Mayeux, R.; Luchsinger, J.A. Mediterranean diet and risk for Alzheimer's disease. Ann. Neurol., 2006, 59, 912-921.
32. Ng, T.P.; Chiam, P.C.; Lee, T.; Chua, H.C.; Lim, L.; Kua, E.H. Curry consumption and cognitive function in the elderly. Am. J. Epidemiol., 2006, 164, 898-906.
33. Pari, L.; Tewas, D.; Eckel, J. Role of curcumin in health and disease. Arch. Physiol. Biochem., 2008, 114(2), 127-149.
34. Menon, V.P.; Sudheer, A.R. Antioxidant and anti-inflammatory properties of curcumin. Adv. Exp. Med. Biol., 2007, 595, 105-125.
35. Kapitulnik, J. Drug transport and metabolism in the blood brain barrier. Front. Pharmacol., 2011, 2, 37.
36. Garcia-Alloza, M.; Borrelli, L.A.; Rozkalne, A.; Hyman, B.T.; Bacskai, B.J. Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model. J. Neurochem., 2007, 102, 1095-1104.
37. Xiong, Z.; Hongmei, Z.; Lu, S.; Yu, L. Curcumin mediates presenilin-1 activity to reduce β-amyloid production in a model of Alzheimer's Disease. Pharmacol. Rep., 2011, 63(5), 1101-1108.
38. Avila, J.; Lucas, J.J.; Perez, M.; Hernandez, F. Role of tau protein in both physiological and pathological conditions. Physiol. Rev., 2004, 84, 361-384.
39. Twomey, C.; McCarthy, J.V. Presenilin-1 is an unprimed glycogen synthase kinase-3beta substrate. FEBS Lett., 2006, 580(17), 4015-4020.
40. Yu, H.; Saura, C.A.; Choi, S.Y.; Sun, L.D; Yang, X.; Handler, M.; Kawarabayashi, T.; Younkin, L.; Fedeles, B.; Wilson, M.A.; Younkin, S.; Kandel, E.R.; Kirkwood, A.; Shen, J. APP processing and synaptic plasticity in presenilin-1 conditional knockout mice. Neuron., 2001, 31(5), 713-726.
41. Zhang, C.; Browne, A.; Child, D.; Tanzi, R.E. Curcumin decreases amyloid-beta peptide levels by attenuating the maturation of amyloidbeta precursor protein. J. Biol. Chem., 2010, 285(37), 28472-28480.
42. Yang, F.; Lim, G.P.; Begum, A.N.; Ubeda, O.J.; Simmons, M.R.; Ambegaokar, S.S.; Chen, P.P.; Kayed, R.; Glabe, C.G.; Frautschy, S.A.; Cole, G.M. Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo. J. Biol. Chem., 2005, 280(7), 5892-5901.
43. Zhang, L.; Fiala, M.; Cashman, J.; Sayre, J.; Espinosa, A.; Mahanian, M.; Zaghi, J.; Badmaev, V.; Graves, M.C.; Bernard, G.; Rosenthal, M. Curcuminoids enhance amyloid-beta uptake by macrophages of Alzheimer's disease patients. J. Alzheimers. Dis., 2006, 10(1), 1-7.
44. Nicoll, J.A.; Wilkinson, D.; Holmes, C.; Steart, P.; Markham, H.; Weller, R.O. Neuropathology of human Alzheimer disease after immunization with amyloid-beta peptide: a case report. Nat. Med., 2003, 9, 448-452.
45. Richartz, E.; Stransky, E.; Batra, A.; Simon, P.; Lewczuk, P.; Buchkremer, G.; Bartels, M.; Schott, K. Decline of immune responsiveness: A pathogenetic factor in Alzheimer's disease? J. Psychiatr. Res., 2005, 39, 535-543.
46. Shimmyo, Y.; Kiharaa, T.; Akaikeb, A.; Niidomea, T.; Sugimotoa, H. Epigallocatechin-3-gallate and curcumin suppress amyloid beta-induced beta-site APP cleaving enzyme-1 upregulation. Neuroreport., 2008, 19(13), 1329-1333.
47. Goshima, Y.; Nakamura, F.; Strittmatter, P.; Strittmatter, S.M. Collapsin-induced growth cone collapse mediated by an intracellular protein related to UNC-33. Nature, 1995, 376(6540), 509-514.
48. Uchida, Y.; Ohshima, T.; Sasaki, Y.; Suzuki, H.; Yanai, S.; Yamashita, N.; Nakamura, F.; Takei, K.; Ihara, Y.; Mikoshiba, K.; Kolattukudy, P.; Honnorat, J.; Goshima, Y. Semaphorin3A signalling is mediated via sequential Cdk5 and GSK3beta phosphorylation of CRMP2: implication of common phosphorylating mechanism underlying axon guidance and Alzheimer's disease. Genes Cells, 2005, 10(2), 165-179.
49. Yoshimura, T.; Kawano, Y.; Arimura, N.; Kawabata, S.; Kikuchi, A.; Kaibuchi, K. GSK-3beta regulates phosphorylation of CRMP-2 and neuronal polarity. Cell, 2005, 120(1), 137-149.
50. Arimura, N.; Ménager, C.; Kawano, Y.; Yoshimura, T.; Kawabata, S.; Hattori, A.; Fukata, Y.; Amano, M.; Goshima, Y.; Inagaki, M.; Morone, N.; Usukura, J.; Kaibuchi, K. Phosphorylation by Rho kinase regulates CRMP-2 activity in growth cones. Mol. Cell. Biol., 2005, 25(22), 9973-9984.
51. Arimura, N.; Inagaki, N.; Chihara, K.; Ménager, C.; Nakamura, N.; Amano, M.; Iwamatsu, A.; Goshima, Y.; Kaibuchi, K. Phosphorylation of collapsin response mediator protein-2 by Rho-kinase-Evidence for two separate signaling pathways for growth cone collapse. J. Biol. Chem., 2000, 275(31), 23973-23980.
52. Petratos, S.; Li, Q.X.; George, A.J.; Hou, X.; Kerr, M.L.; Unabia, S.E.; Hatzinisiriou, I.; Maksel, D.; Aguilar, M.I.; Small, D.H. The beta-amyloid protein of Alzheimer's disease increases neuronal CRMP-2 phosphorylation by a Rho-GTP mechanism. Brain, 2008, 131(Pt 1), 90-108.
53. Wang, Y.; Yin, H.; Li, J.; Zhang, Y.; Han, B.; Zeng, Z.; Qiao, N.; Cui, X.; Lou, J.; Li, J. Amelioration of β-amyloid-induced cognitive dysfunction and hippocampal axon degeneration by curcumin is associated with suppression of CRMP-2 hyperphosphorylation. Neurosci. Lett., 2013, 557(Pt B), 112-117.
54. Morfini, G.A.; Burns, M.; Binder, L.I.; Kanaan, N.M.; LaPointe, N.; Bosco, D.A.; Brown, R.H. Jr.; Brown, H.; Tiwari, A.; Hayward, L.; Edgar, J.; Nave, K.A.; Garberrn, J.; Atagi, Y.; Song, Y.; Pigino, G.; Brady, S.T. Axonal transport defects in neurodegenerative diseases. J. Neurosci., 2009, 29, 12776-12786.
55. Sheng, Z.H.; Cai, Q. Mitochondrial transport in neurons: impact on synaptic homeostasis and neurodegeneration. Nat. Rev. Neurosci., 2012, 13, 77-93.
56. Ma, Q.L.; Zuo, X.; Yang, F.; Ubeda, O.J.; Gant, D.J.; Alaverdyan, M.; Teng, E.; Hu, S.; Chen, P.P.; Maiti, P.; Teter, B.; Cole, G.M.; Frautschy, S.A. Curcumin suppresses soluble tau dimers and corrects molecular chaperone, synaptic, and behavioral deficits in aged human tau transgenic mice. J. Biol. Chem., 2013, 288(6), 4056-4065.
57. Heneka, M.T.; O'Banion, M.K.; Terwel, D.; Kummer, M.P. Neuroinflammatory processes in Alzheimer's disease. J. Neural. Transm., 2010, 117(8), 919-947.
58. Kuner, P.; Schubenel, R., Hertel, C. β-amyloid binds to p75ntr and activates NFkB in human neuroblastoma cells. J. Neurosci. Res., 1998, 54, 798-804.
59. Bass, T.M.; Weinkove, D.; Houthoofd, K.; Gems, D.; Partridge, L. Effects of resveratrol on lifespan in Drosophila melanogaster and Caenorhabditis elegans. Mech. Ageing Dev., 2007, 128(10), 546-552.
60. Howitz, K.T.; Bitterman, K.J.; Cohen, H.Y.; Lamming, D.W.; Lavu, S.; Wood, J.G.; Zipkin, R.E.; Chung, P.; Kisielewski, A.; Zhang, L.L.; Scherer, B.; Sinclair, D.A. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature, 2003, 425(6954), 191-196.
61. Ladiwala, A.R.; Lin, J.C.; Bale, S.S.; Marcelino-Cruz, A.M.; Bhattacharya, M.; Dordick, J.S.; Tessier, P.M. Resveratrol selectively remodels soluble oligomers and fibrils of amyloid Abeta into offpathway conformers. J. Biol. Chem., 2010, 285(31), 24228-24237.
62. Capiralla, H.; Vingtdeux, V.; Zhao, H.; Sankowski, R.; Al-Abed, Y.; Davies, P.; Marambaud, P. Resveratrol mitigates lipopolysaccharide-and A β-mediated microglial inflammation by inhibiting the TLR4/NF-κB/STAT signaling cascade. J. Neurochem., 2012, 120(3), 461-472.
63. Gertz, M.; Nguyen, G.T.T.; Fischer, F.; Suenke, B.; Schlicker, C.; Fränzel, B.; Tomaschewski, J.; Aladini, F.; Becker, C.; Wolters, D.; Steegborn, C. A molecular mechanism for direct sirtuin activation by resveratrol. Plos One, 2012, 7(11), e49761.
64. Orgogozo, J.M.; Dartigues, J.F.; Lafont, S.; Letenneur, L.; Commenges, D.; Salamon, R.; Renaud, S.; Breteler, M.B. Wine consumption and dementia in the elderly: a prospective community study in the Bordeaux area. Rev. Neurol. (Paris), 1997, 153(3), 185-192.
65. Han, Y.S.; Zheng, W.H.; Bastianetto, S.; Chabot, J.G.; Quirion, R. Neuroprotective effects of resveratrol against beta-amyloid-induced neurotoxicity in rat hippocampal neurons: Involvement of protein kinase C. Br. J. Pharmacol., 2004, 141(6), 997-1005.
66. Abou-Agag, L.H.; Aikens, M.L.; Tabengwa, E.M.; Benza, R.L.; Shows, S.R.; Grenett, H.E.; Booyse, F.M. Polyphyenolics increase t-PA and u-PA gene transcription in cultured human endothelial cells. Alcohol Clin. Exp. Res., 2001, 25(2), 155-162.
67. Melchor, J.P.; Pawlak, R.; Strickland, S. The tissue plasminogen activator-plasminogen proteolytic cascade accelerates amyloid-beta (Abeta) degradation and inhibits Abeta-induced neurodegeneration. J. Neurosci., 2003, 23(26), 8867-8871.
68. Morselli E.; Maiuri, M.C.; Markaki, M.; Megalou, E.; Pasparaki, A.; Palikaras, K.; Criollo, A.; Galluzzi, L.; Malik, S.A.; Vitale, I.; Michaud, M.; Madeo, F.; Tavernarakis, N.; Kroemer, G. Caloric restriction and resveratrol promote longevity through the Sirtuin-1-dependent induction of autophagy. Cell Death Dis., 2010, 1, e10.
69. Wang, J.; Fivecoat, H.; Ho, L.; Pan, Y.; Ling, E.; Pasinetti, G.M. The role of Sirt1: at the crossroad between promotion of longevity and protection against Alzheimer's disease neuropathology. Biochem. Biophys. Acta., 2010, 1804(8), 1690-1694.
70. Salminen, A.; Kauppinen, A.; Suuronen, T.; Kaarniranta, K. SIRT1 longevity factor suppresses NF-kappaB-driven immune responses: Regulation of aging via NF-kappaB acetylation? Bioessays., 2008, 30(10), 939-942.
71. Donmez, G., Wang, D.; Cohen, D.E.; Guarente, L. SIRT1 suppresses beta-amyloid production by activating the alpha-secretase gene ADAM10. Cell, 2010, 142(2), 320-332.
72. Luo, J.; Nikolaev, A.Y.; Imai, S.; Chen, D.; Su, F.; Shiloh, A.; Guarente, L.; Gu, W. Negative control of p53 by Sir2alpha promotes cell survival under stress. Cell, 2001, 107(2), 137-148.
73. Qin, W.; Yang, T.; Ho, L.; Zhao, Z.; Wang, J.; Chen, L.; Zhao, W.; Thiyagarajan, M.; MacGrogan, D.; Rodgers, J.T.; Puigserver, P.; Sadoshima, J.; Deng, H.; Pedrini, S.; Gandy, S.; Sauve, A.A.; Pasinetti, G.M. Neuronal SIRT1 activation as a novel mechanism underlying the prevention of Alzheimer disease amyloid neuropathology by calorie restriction. J. Biol. Chem., 2006, 281(31), 21745-21754.
74. Kim, D.; Nguyen, M.D.; Dobbin, M.M.; Fischer, A.; Sananbenesi, F.; Rodgers, J.T.; Delalle, I.; Baur, J.A.; Sui, G.; Armour, S.M.; Puigserver, P.; Sinclair, D.A.; Tsai, L.H. SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer's disease and amyotrophic lateral sclerosis. EMBO J., 2007, 26(13), 3169-3179.
75. Higashida, K.; Kim, S.H.; Jung, S.R.; Asaka, M.; Holloszy, J.O.; Han, D.H. Effects of resveratrol and SIRT1 on PGC-1α activity and mitochondrial biogenesis: a reevaluation. PLoS Biol., 2013, 11(7), e1001603.
76. Kumar, A.; Sharma, S.S. NF-kappaB inhibitory action of resveratrol: a probable mechanism of neuroprotection in experimental diabetic neuropathy. Biochem. Biophys. Res. Commun., 2010, 394(2), 360-365.
77. Zhu, X.; Liu, Q.; Wang, M.; Liang, M.; Yang, X.; Xu, X.; Zou, H.; Qiu, J. Activation of Sirt1 by Resveratrol Inhibits TNF-a Induced Inflammation in Fibroblasts. PLoS One., 2011, 6(11), e27081.
78. Weinreb, O.; Amit, T.; Mandel, S.; Youdim, M.B. Neuroprotective molecular mechanisms of (-)-epigallocatechin-3-gallate: A reflective outcome of its antioxidant, iron chelating and neuritogenic properties. Genes Nutr., 2009, 4(4), 283-296.
79. Faria, A.; Pestana, D.; Teixeira, D.; Couraud, P.O.; Romero, I.; Weksler, B.; de Freitas, V.; Mateus, N.; Calhau, C. Insights into the putative catechin and epicatechin transport across blood-brain barrier. Food Funct., 2011, 2(1), 39-44.
80. Okello, E.J.; Leylabi, R.; McDougall, G.J. Inhibition of acetylcholinesterase by green and white tea and their simulated intestinal metabolites. Food Funct., 2012, 3(6), 651-661.
81. Wang, S.H.; Dong, X.Y.; Sun, Y. Thermodynamic analysis of the molecular interactions between amyloid β-protein fragments and (-)-epigallocatechin-3-gallate. J. Phys. Chem. B, 2012, 116(20), 5803-5809.
82. Fernandez, J.W.; Rezai-Zadeh, K.; Obregon, D.; Tan, J. EGCG functions through estrogen receptor-mediated activation of ADAM10 in the promotion of non-amyloidogenic processing of APP. FEBS Lett., 2010, 584(19), 4259-4267.
83. Rezai-Zadeh, K.; Shytle, D.; Sun, N.; Mori, T.; Hou, H.; Jeanniton, D.; Ehrhart, J.; Townsend, K.; Zeng, J.; Morgan, D.; Hardy J.; Town, T.; Tan, J. Green tea epigallocatechin-3-gallate (EGCG) modulates amyloid precursor protein cleavage and reduces cerebral amyloidosis in Alzheimer transgenic mice. J. Neurosci., 2005, 25(38), 8807-8814.
84. Lee, J.W.; Lee, Y.K.; Ban, J.O.; Ha, T.Y.; Yun, Y.P.; Han, S.B.; Oh, K.W.; Hong, J.T. Green tea (-)-epigallocatechin-3-gallate inhibits beta-amyloid-induced cognitive dysfunction through modification of secretase activity via inhibition of ERK and NF-kappaB pathways in mice. J. Nutr., 2009, 139(10), 1987-1993.
85. Levites, Y.; Amit, T.; Mandel, S.; Youdim, M.B. Neuroprotection and neurorescue against Abeta toxicity and PKC-dependent release of nonamyloidogenic soluble precursor protein by green tea polyphenol (-)-epigallocatechin-3-gallate. FASEB J., 2003, 17(8), 952-954.
86. Battaini, F. Protein kinase C isoforms as therapeutic targets in nervous system disease states. Pharmacol. Res., 2001, 44, 353-361.
87. Huang, L.; Liu, Y.; Jin, W.; Ji, X.; Dong, Z. Ketamine potentiates hippocampal neurodegeneration and persistent learning and memory impairment through the PKCgamma-ERK signaling pathway in the developing brain. Brain. Res., 2012, 1476, 164-171.
88. Choi, D.S.; Wang, D.; Yu, G.Q.; Zhu, G.; Kharazia, V.N.; Paredes, J.P.; Chang, W.S.; Dietchman, J.K.; Mucke, L.; Messing, R.O. PKCε increases endothelin converting enzyme activity and reduces amyloid plaque pathology in transgenic mice. Proc. Natl. Acad. Sci. USA., 2006, 103(21), 8215-8220.
89. Kalfon, L.; Youdim, M.B.; Mandel, S.A. Green tea polyphenol (-)-epigallocatechin-3-gallate promotes the rapid protein kinase C-and proteasome-mediated degradation of Bad: implications for neuroprotection. J. Neurochem., 2007, 100(4), 992-1002.
90. Mandel, S.; Reznichenko, L.; Amit, T.; Youdim, M.B. Green tea polyphenol (-)-epigallocatechin-3-gallate protects rat PC12 cells from apoptosis induced by serum withdrawal independent of P13-Akt pathway. Neurotox. Res., 2003, 5(6), 419-424.
91. Rezai-Zadeh, K.; Arendash, G.W.; Hou, H.; Fernandez, F.; Jensen, M.; Runfeldt, M.; Shytle, R.D.; Tan, J. Green tea epigallocatechin-3-gallate (EGCG) reduces beta-amyloid mediated cognitive impairment and modulates tau pathology in Alzheimer transgenic mice. Brain Res., 2008, 1214, 177-187.
92. Ng, T.P.; Feng, L.; Niti, M.; Kua, E.H.; Yap, K.B. Tea consumption and cognitive impairment and decline in older Chinese adults. Am. J. Clin. Nutr., 2008, 88, 224-231.
93. Feng, L.; Gwee, X.; Kua, E.H.; Ng, T.P. Cognitive function and tea consumption in community dwelling older Chinese in Singapore. J. Nutr. Health. Aging, 2010, 14(6), 433-438.
94. Arai, Y.; Watanabe, S.; Kimira, M.; Shimoi, K.; Mochizuki, R.; Kinae, N. Dietary intakes of flavonols, flavones and isoflavones by Japanese women and the inverse correlation between quercetin intake and plasma LDL cholesterol concentration. J. Nutr., 2000, 130, 2243-2250
95. Maher, P.; Akaishi, T.; Abe, K. Flavonoid fisetin promotes ERKdependent long-term potentiation and enhances memory. Proc. Natl. Acad. Sci. USA., 2006, 103(44), 16568-16573.
96. Nakajima, A.; Yamakuni, T.; Matsuzaki, K.; Nakata, N.; Onozuka, H.; Yokosuka, A.; Sashida, Y.; Mimaki, Y.; Ohizumi, Y. Nobiletin, a citrus flavonoid, reverses learning impairment associated with Nmethyl-D-aspartate receptor antagonism by activation of extracellular signal-regulated kinase signaling. J. Pharmacol. Exp. Ther., 2007, 321(2), 784-790.
97. Yin, J.C.; Del Vecchio, M.; Zhou, H.; Tully, T. CREB as a memory modulator: induced expression of a dCREB2 activator isoform enhances long-term memory in Drosophila. Cell, 1995, 81(1), 107-115.
98. Kuhn, H.; Saam, J.; Eibach, S.; Holzhutter, H.G.; Ivanov, I.;Walther, M. Structural biology of mammalian lipoxygenases: Enzymatic consequences of targeted alterations of the protein structure. Biochem. Biophys. Res. Commun., 2005, 338, 93-101.
99. Lammers, C.H.; Schweitzer, P.; Facchinetti, P.; Arrang, J.M.; Madamba, S.G.; Siggins, G.R.; Piomelli, D. Arachidonate 5-lipoxygenase and its activating protein: prominent hippocampal expression and role in somatostatin signaling. J. Neurochem., 1996, 66,147-152.
100. Manev, H.; Uz, T.; Sugaya, K.; Qu, T. Putative role of neuronal 5-lipoxygenase in an aging brain. FASEB J. 2000, 14(10), 1464-1469.
101. Chu, J.; Pratico, D. 5-Lipoxygenase as an endogenous modulator of amyloid beta formation in vivo. Ann. Neurol., 2011, 69(1), 34-46.
102. Maher, P. Modulation of multiple pathways involved in the maintenance of neuronal function during aging by fisetin. Genes Nutr., 2009, 4(4), 297-307.
103. Tank, E.M.; True, H.L. Disease-associated mutant ubiquitin causes proteasomal impairment and enhances the toxicity of protein aggregates. PLoS Genet., 2009, 5(2), e1000382.
104. Akaishi, T.; Morimoto, T.; Shibao, M.; Watanabe, S.; Sakai-Kato, K.; Utsunomiya-Tate, N.; Abe, K. Structural requirements for the flavonoid fisetin in inhibiting fibril formation of amyloid beta protein. Neurosci. Lett., 2008, 444(3), 280-285.
105. Currais, A.; Prior, M.; Dargusch, R.; Armando, A.; Ehren, J.; Schubert, D.; Quehenberger, O.; Maher, P. Modulation of p25 and inflammatory pathways by fisetin maintains cognitive function in Alzheimer's disease transgenic mice. Aging Cell, 2013, doi: 10.1111/acel.12185.
106. Hendriks, J.J.; de Vries, H.E.; van der Pol, S.M.; van den Berg, T.K.; van Tol, E.A.; Dijkstra, C.D. Flavonoids inhibit myelin phagocytosis by macrophages; a structure-activity relationship study. Biochem. Pharmacol., 2003, 65(5), 877-885.
107. Abell, C.W.; Kwan, S.W. Molecular characterization of monoamine oxidases A and B. Prog. Nucleic Acid Res. Mol. Biol., 2001, 65, 129-156.
108. Zhen, L.; Zhu, J.; Zhao, X.; Huang, W.; An, Y.; Li, S.; Du, X.; Lin, M.; Wang, Q.; Xu, Y.; Pan, J. The antidepressant-like effect of fisetin involves the serotonergic and noradrenergic system. Behav. Brain Res., 2012, 228(2), 359-366.
109. Velasquez, M.T.; Bhathena, S.J. Role of dietary soy protein in obesity. Int. J. Med. Sci., 2007, 4(2), 72-82.
110. Kao, T.H.; Chen, B.H. Functional components in soybean cake and their effects on antioxidant activity. J. Agric. Food Chem., 2006, 54, 7544-7555.
111. Kao, T.H.; Wu, W.M.; Hung, C.F.; Wu, W.B.; Chen, B.H. Antiinflammatory effects of isoflavone powder produced from soybean cake. J. Agric. Food Chem., 2007, 55, 11068-11079.
112. Tsunoda, N.; Pomeroy, S.; Nestel, P. Absorption in humans of isoflavones from soy and red clover is similar. J. Nutr., 2002, 132, 2199-2201.
113. Rochester, J.R.; Millam, J.R. Phytoestrogens and avian reproduction: exploring the evolution and function of phytoestrogens and possible role of plant compounds in the breeding ecology of wild birds. Comp. Biochem. Physiol. A Mol. Integr. Physiol., 2009, 154, 279-288.
114. Wharton, W.; Baker, L.D.; Gleason, C.E.; Dowling, M.; Barnet, J.H.; Johnson, S.; Carlsson, C.; Craft, S.; Asthana, S. Short-term hormone therapy with transdermal estradiol improves cognition for postmenopausal women with Alzheimer's disease: results of a randomized controlled trial. J. Alzheimers Dis., 2011, 26(3), 495-505.
115. Goodenough, S.; Schäfer, M.; Behl, C. Estrogen-induced cell signalling in a cellular model of Alzheimer's disease. J. Steroid. Biochem. Mol. Biol., 2003, 84(2-3), 301-305.
116. Sarajärvi, T.; Haapasalo, A.; Viswanathan, J.; Mäkinen, P.; Laitinen, M.; Soininen, H.; Hiltunen, M. Down-regulation of seladin-1 increases BACE1 levels and activity through enhanced GGA3 depletion during apoptosis. J. Biol. Chem., 2009, 284(49), 34433-34443.
117. Benvenuti, S.; Luciani, P.; Vannelli, G.B.; Gelmini, S.; Franceschi, E.; Serio, M.; Peri, A. Estrogen and selective estrogen receptor modulators exert neuroprotective effects and stimulate the expression of selective Alzheimer's disease indicator-1, a recently discovered antiapoptotic gene, in human neuroblast long-term cell cultures. J. Clin. Endocrinol. Metab., 2005, 90(3), 1775-1782.
118. Luciani, P.; Deledda, C.; Rosati, F.; Benvenuti, S.; Cellai, I.; Dichiara, F.; Morello, M.; Vannelli, G.B.; Danza, G.; Serio, M.; Peri, A. Seladin-1 is a fundamental mediator of the neuroprotective effects of estrogen in human neuroblast long-term cell cultures. Endocrinology, 2008, 149(9), 4256-4266.
119. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Lancet, 1997, 350, 1047-1059.
120. Beresford, S.A.A.; Weiss, N.S.; McKnight, B. Risk of endometrial cancer in relation to use of oestrogen combined with cyclic progestagen therapy in postmenopausal women. Lancet, 1997, 349, 458-461.
121. Chen, X.; Anderson, J.J. Isoflavones inhibit proliferation of ovarian cancer cells in vitro via an estrogen receptor-dependent pathway. Nutr. Cancer, 2001, 41(1-2), 165-71.
122. Brown, A.; Jolly, P.; Wei, H. Genistein modulates neuroblastoma cell proliferation and differentiation through induction of apoptosis and regulation of tyrosine kinase activity and N-myc expression. Carcinogenesis, 1998, 19(6), 991-997.
123. Safahani, M.; Amani, R.; Aligholi, H.; Sarkaki, A.; Badavi, M.; Moghaddam, A.Z.; Haghighizadeh, M.H. Effect of Different Doses of Soy Isoflavones on Spatial Learning and Memory in Ovariectomized Rats. Basic Clin. Neurosci., 2011, 2(4),12-18.
124. Hirohata, M.; Ono, K.; Takasaki, J.; Takahashi, R.; Ikeda, T.; Morinaga, A.; Yamada, M. Anti-amyloidogenic effects of soybean isoflavones in vitro: Fluorescence spectroscopy demonstrating direct binding to Aβ monomers, oligomers and fibrils. Biochem. Biophys. Acta., 2012, 1822(8), 1316-24.
125. Gutierrez-Zepeda, A.; Santell, R.; Wu, Z.; Brown, M.; Wu, Y.; Khan, I.; Link, C.D.; Zhao, B.; Luo, Y. Soy isoflavone glycitein protects against beta amyloid-induced toxicity and oxidative stress in transgenic Caenorhabditis elegans. BMC Neurosci., 2005, 6, 54.
126. Kuchibhotla, K.V.; Goldman, S.T.; Lattarulo, C.R.; Wu, H.; Hyman, B.T.; Bacskai, B.J. Aβ plaques lead to aberrant regulation of calcium homeostasis in vivo resulting in structural and functional disruption of neuronal networks. Neurons, 2009, 59(2), 214-225.
127. Zeng, H.; Chen, Q.; Zhao, B. Genistein ameliorates beta-amyloid peptide (25-35)-induced hippocampal neuronal apoptosis. Free. Radic. Biol. Med., 2004, 36(2), 180-188.
128. Lund, T.D.; West, T.W.; Tian, L.Y.; Bu, L.H.; Simmons, D.L.; Setchell, K.D.; Adlercreutz, H.; Lephart, E.D. Visual spatial memory is enhanced in female rats (but inhibited in males) by dietary soy phytoestrogens. BMC Neurosci., 2001, 2, 20.
129. Iacopino, A.M.; Christakos, S. Specific reduction of calciumbinding protein (28-kilodalton calbindin-D) gene expression in aging and neurodegenerative diseases. Proc. Natl. Acad. Sci. USA., 1990, 87(11), 4078-4082.
130. 25-35 -induced neurotoxicity in PC12 cells via PKC signaling pathway. Neurochem. Res., 2012, 37(12), 2787-2794.
131. Zhao, L.; Wang, J.L.; Wang, Y.R.; Fa, X.Z. Apigenin attenuates copper-mediated β-amyloid neurotoxicity through antioxidation, mitochondrion protection and MAPK signal inactivation in an AD cell model. Brain Res. 2013, 1492, 33-45.
132. Zhao, L.; Hou, L.; Sun, H.; Yan, X.; Sun, X.; Li, J.; Bian, Y.; Chu, Y.; Liu, Q. Apigenin isolated from the medicinal plant Elsholtzia rugulosa prevents β-amyloid 25-35-induces toxicity in rat cerebral microvascular endothelial cells. Molecules, 2011, 16(5), 4005-4019.
133. Ryu, J.; Girigoswami, K.; Ha, C.; Ku, S.H.; Park, C.B. Influence of multiple metal ions on beta-amyloid aggregation and dissociation on a solid surface. Biochemistry, 2008, 47(19), 5328-5335.
134. Rezai-Zadeh, K.; Ehrhart, J.; Bai, Y.; Sanberg, P.R.; Bickford, P.; Tan, J.; Shytle, R.D. Apigenin and luteolin modulate microglial activation via inhibition of STAT1-induced CD40 expression. J. Neuroinflammation., 2008, 5, 41.
135. Tan, J.; Town, T.; Paris, D.; Mori, T.; Suo, Z.; Crawford, F.; Mattson, M.P.; Flavell, R.A.; Mullan, M. Microglial activation resulting from CD40-CD40L interaction after beta-amyloid stimulation. Science, 1999, 286(5448), 2352-2355.
136. Sundaram, S.; Gowtham, L.; Nayak, B.S. The role of excitatory neurotransmitter glutamate in bain physiology and pathology. Asian J. Pharm. Clin. Res., 2012, 5(2), 1-7.
137. Sattler, R.; Tymianski, M. Molecular mechanisms of calciumdependent excitotoxicity. J. Mol. Med. (Berl)., 2000, 78(1), 3-13.
138. Han, J.H.; Kim, K.J.; Jang, H.J.; Jang, J.H.; Kim, M.J.; Sung, K.W.; Rhie, D.J.; Jo, Y.H.; Hahn, S.J.; Lee, M.Y.; Yoon, S.H. Effects of Apigenin on Glutamate-induced [Ca](i) Increases in Cultured Rat Hippocampal Neurons. Korean J. Physiol. Pharmacol., 2008, 12(2), 43-9.
139. Gomez-Pinilla, F.; Vaynman, S.; Ying, Z. Brain-derived neurotrophic factor functions as a metabotrophin to mediate the effects of exercise on cognition. Eur. J. Neurosci., 2008, 28(11), 2278-2287.
140. Garzon, D.J.; Fahnestock, M. Oligomeric amyloid decreases basal levels of brain-derived neurotrophic factor (BDNF) mRNA via specific downregulation of BDNF transcripts IV and V in differentiated human neuroblastoma cells. J. Neurosci., 2007, 27(10), 628-35.
141. Srinivasan, M.; Sudheer, A.R.; Menon, V.P. Ferulic acid: therapeutic potential through its antioxidant property. J. Clin. Biochem. Nutr., 2007, 40, 92-100.
142. Jagota, S.; Rajadas, J. Effect of phenolic compounds against Ab aggregation and Ab-induced toxicity in transgenic C. elegans. Neurochem. Res., 2012, 37(1), 40-48.
143. Ono, K; Hirohata, M; Yamada, M. Ferulic acid destabilizes preformed beta-amyloid fibrils in vitro. Biochem. Biophys. Res. Commun., 2005, 336, 444-449.
144. Picone, P.; Nuzzo, D.; Di Carlo, M. Ferulic acid: a natural antioxidant against oxidative stress induced by oligomeric A-beta on sea urchin embryo. Biol. Bull., 2013, 224(1), 18-28.
145. Yan, J.J.; Cho, J.Y.; Kim, H.S.; Kim, K.L.; Jung, J.S.; Huh, S.O.; Suh, H.W.; Kim, Y.H.; Song, D.K. Protection against beta-amyloid peptide toxicity in vivo with long-term administration of ferulic acid. Br. J. Pharmacol. 2001, 133(1), 89-96.
146. Mori, T.; Koyama, N.; Guillot-Sestier, M.; Tan, J.; Town, T. Ferulic acid is a nutraceutical b-secretase modulator that improves behavioral impairment and alzheimer-like pathology in transgenic mice. Plos One, 2013, 8(2), e55774.
147. Esterbauer, H.; Schaur, R.J.; Zollner, H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic. Biol. Med., 1991, 11, 81-128.
148. Castegna, A.; Lauderback, C.M.; Mohmmad-Abdul, H.; Butterfield, D.A. Modulation of phospholipid asymmetry in synaptosomal membranes by the lipid peroxidation products, 4-hydroxynonenal and acrolein: implications for Alzheimer's disease. Brain Res., 2004, 1004(1-2), 193-197.
149. Mohmmad Abdul, H.; Butterfield, D.A. Protection against amyloid beta-peptide (1-42)-induced loss of phospholipid asymmetry in synaptosomal membranes by tricyclodecan-9-xanthogenate (D609) and ferulic acid ethyl ester: implications for Alzheimer's disease. Biochim. Biophys. Acta, 2005, 1741(1-2), 140-148.
150. Koh, P.O. Ferulic acid attenuates the injury-induced decrease of protein phosphatase 2A subunit B in ischemic brain injury. PLoS One, 2013, 8(1), e54217.
151. Zolnierowicz, S. Type 2A protein phosphatase, the complex regulator of numerous signaling pathways. Biochem. Pharmacol., 2000, 60, 1225-1235.
152. Sontag, E.; Hladik, C.; Montgomery, L.; Luangpirom, A.; Mudrak, I.; Ogris, E.; White, C.L. Downregulation of protein phosphatase 2A carboxyl methylation and methyltransferase may contribute to Alzheimer disease pathogenesis. J. Neuropathol. Exp. Neurol., 2004, 63(10), 1080-1091.
153. Biradar, S.M.; Joshi, H.; Chheda, T.K. Neuropharmacological effect of Mangiferin on brain cholinesterase and brain biogenic amines in the management of Alzheimer's disease. Eur. J. Pharmacol., 2012, 683(1-3), 140-147.
154. Lemus-Molina, Y.; Sánchez-Gómez, M.V.; Delgado-Hernández, R.; Matute, C. Mangifera indica L. extract attenuates glutamateinduced neurotoxicity on rat cortical neurons. Neurotoxicology, 2009, 30(6), 1053-1058.
155. Wang, D.; Li, S.; Zhu, X.; Wang, Y.; Wu, W.; Zhang, X. Protective Effects of Hesperidin against Amyloid-b (Ab) Induced Neurotoxicity Through the Voltage Dependent Anion Channel 1 (VDAC1)-Mediated Mitochondrial Apoptotic Pathway in PC12 Cells. Neurochem. Res., 2013, 38, 1034-1044.
156. Huang, S.M.; Tsai, S.Y.; Lin, J.A.; Wu, C.H.; Yen, G.C. Cytoprotective effects of hesperetin and hesperidin against amyloid β-induced impairment of glucose transport through downregulation of neuronal autophagy. Mol. Nutr. Food Res., 2012, 56(4), 601-609.
157. Wang, S.W.; Wang, Y.J.; Su, Y.J.; Zhou, W.W.; Yang, S.G.; Zhang, R.; Zhao, M.; Li, Y.N.; Zhang, Z.P.; Zhan, D.W.; Liu, R.T. Rutin inhibits β-amyloid aggregation and cytotoxicity, attenuates oxidative stress, and decreases the production of nitric oxide and proinflammatory cytokines. Neurotoxicology, 2012, 33(3), 482-490.
158. Moghbelinejad, S.; Nassiri-Asl, M.; Farivar, T.N.; Abbasi, E.; Sheikhi, M.; Taghiloo, M.; Farsad, F.; Samimi, A.; Hajiali, F. Rutin activates the MAPK pathway and BDNF gene expression on betaamyloid induced neurotoxicity in rats. Toxicol. Lett., 2014, 224(1), 108-113.
159. Tarozzi, A.; Morroni, F.; Merlicco, A.; Bolondi, C.; Teti, G.; Falconi, M.; Cantelli-Forti, G.; Hrelia, P. Neuroprotective effects of cyanidin 3-O-glucopyranoside on amyloid beta (25-35) oligomerinduced toxicity. Neurosci. Lett., 2010, 473(2),72-76.
160. Kim, J.K.; Choi, S.J.; Cho, H.Y.; Hwang, H.J.; Kim, Y.J.; Lim, S.T.; Kim, C.J.; Kim, H.K.; Peterson, S.; Shin, D.H. Protective effects of kaempferol (3,4',5,7-tetrahydroxyflavone) against amyloid beta peptide (Abeta)-induced neurotoxicity in ICR mice. Biosci. Biotechnol. Biochem., 2010, 74(2), 397-401.
161. Sharoar, M.G.; Thapa, A.; Shahnawaz, M.; Ramasamy, V.S.; Woo, E.R.; Shin, S.Y.; Park, I.S. Keampferol-3-O-rhamnoside abrogates amyloid beta toxicity by modulating monomers and remodeling oligomers and fibrils to non-toxic aggregates. J. Biomed. Sci., 2012, 19, 104.
162. Choi, R.C.; Zhu, J.T.; Yung, A.W.; Lee, P.S.; Xu, S.L.; Guo, A.J.; Zhu, K.Y.; Dong, T.T; Tsim, K.W. Synergistic Action of Flavonoids, Baicalein, and Daidzein in Estrogenic and Neuroprotective Effects: A Development of Potential Health Products and Therapeutic Drugs against Alzheimer's Disease. Evid. Based Complement Alternat. Med., 2013, 635694.
163. Richard, T.; Poupard, P.; Nassra, M.; Papastamoulis, Y.; Iglésias, M.L.; Krisa, S.; Waffo-Teguo, P.; Mérillon, J.M.; Monti, J.P. Protective effect of ε-viniferin on β-amyloid peptide aggregation investigated by electrospray ionization mass spectrometry. Bioorg. Med. Chem., 2011, 19(10), 3152-3155.
164. Cornejo, A.; Jiménez, J.M.; Caballero, L.; Melo, F.; Maccioni, R.B. Fulvic acid inhibits aggregation and promotes disassembly of tau fibrils associated with Alzheimer's disease. J. Alzheimers Dis., 2011, 27(1), 143-153.
165. Gresa-Arribas, N.; Serratosa, J.; Saura, J.; Sola, C. Inhibition of CCAAT/enhancer binding protein δ expression by chrysin in microglial cells results in anti-inflammatory and neuroprotective effects. J. Neurochem., 2010, 115(2), 526-536.
166. Sul, D.; Kim, H.S.; Lee, D.; Joo, S.S.; Hwang, K.W.; Park, S.Y. Protective effect of caffeic acid against beta-amyloid-induced neurotoxicity by the inhibition of calcium influx and tau phosphorylation. Life Sci., 2009, 84(9-10), 257-262.
167. Kim, M.J.; Seong, A.R.; Yoo, J.Y.; Jin, C.H.; Lee, Y.H.; Kim, Y.J.; Lee, J.; Jun, W.J.; Yoon, H.G. Gallic acid, a histone acetyltransferase inhibitor, suppresses β-amyloid neurotoxicity by inhibiting microglial-mediated neuroinflammation. Mol. Nutr. Food Res., 2011, 55(12), 1798-1808.
168. Ansari, M.A.; Abdul, H.M.; Joshi, G.; Opii, W.O.; Butterfield, D.A. Protective effect of quercetin in primary neurons against Abeta(1-42): Relevance to Alzheimer's disease. J. Nutr. Biochem., 2009, 20(4), 269-275.
169. Yang, E.J.; Kim, G.S.; Kim, J.A.; Song, K.S. Protective effects of onion-derived quercetin on glutamate-mediated hippocampal neuronal cell death. Pharmacogn. Mag., 2013, 9(36), 302-308.
170. Hornick, A.; Lieb, A.; Vo, N.P.; Rollinger, J.M.; Stuppner, H.; Prast, H. The coumarin scopoletin potentiates acetylcholine release from synaptosomes, amplifies hippocampal long-term potentiation and ameliorates anticholinergic-and age-impaired memory. Neuroscience, 2011, 197, 280-292.
171. Ono, K.; Hasegawa, K.; Naiki, H.; Yamada, M. Anti-amyloidogenic activity of tannic acid and its activity to destabilize Alzheimer's beta-amyloid fibrils in vitro. Biochem. Biophys. Acta., 2004, 1690(3), 193-202.
172. Mori, T.; Rezai-Zadeh, K.; Koyama, N.; Arendash, G.W.; Yamaguchi, H.; Kakuda, N.; Horikoshi-Sakuraba, Y.; Tan, J.; Town, T. Tannic acid is a natural β-secretase inhibitor that prevents cognitive impairment and mitigates Alzheimer-like pathology in transgenic mice. J. Biol. Chem., 2012, 287(9), 6912-6927.
173. Cheng, H.Y.; Hsieh, M.T.; Tsai, F.S.; Wu, C.R.; Chiu, C.S.; Lee, M.M.; Xu, H.X.; Zhao, Z.Z.; Peng, W.H. Neuroprotective effect of luteolin on amyloid beta protein (25-35)-induced toxicity in cultured rat cortical neurons. Phytother. Res., 2010, 24(1), S102-S108.
174. Tsai, F.S.; Cheng, H.Y.; Hsieh, M.T.; Wu, C.R.; Lin, Y.C.; Peng, W.H. The ameliorating effects of luteolin on beta-amyloid-induced impairment of water maze performance and passive avoidance in rats. Am. J. Chin. Med., 2010, 38(2), 279-291.
175. Lin, L.F.; Chiu, S.P.; Wu, M.J.; Chen, P.Y.; Yen, J.H. Luteolin Induces microRNA-132 Expression and Modulates Neurite Outgrowth in PC12 Cells. Plos One, 2012, 7(8), e43304
176. Fallarini, S.; Miglio, G.; Paoletti, T.; Minassi, A.; Amoruso, A.; Bardelli, C.; Brunelleschi, S.; Lombardi, G. Clovamide and rosmarinic acid induce neuroprotective effects in in vitro models of neuronal death. Br. J. Pharmacol., 2009, 157(6), 1072-1084.
177. Iuvone, T.; De Filippis, D.; Esposito, G.; D'Amico, A.; Izzo, A.A. The spice sage and its active ingredient rosmarinic acid protect PC12 cells from amyloid-beta peptide-induced neurotoxicity. J. Pharmacol. Exp. Ther., 2006, 317(3), 1143-1149.
178. Feng, Y.; Yang, S.G.; Du, X.T.; Zhang, X.; Sun, X.X.; Zhao, M.; Sun, G.Y.; Liu, R.T. Ellagic acid promotes Abeta42 fibrillization and inhibits Abeta42-induced neurotoxicity. Biochem. Biophys. Res. Commun., 2009, 390(4), 1250-1254.
179. Grossi, C.; Rigacci, S.; Ambrosini, S.; Dami, T.E.; Luccarini, I.; Traini, C.; Failli, P.; Berti, A.; Casamenti, F.; Stefani, M. The Polyphenol Oleuropein Aglycone Protects TgCRND8 Mice against Aß Plaque Pathology. PLoS ONE., 2013, 8(8), e71702.
180. Abuznait, A.H.; Qosa, H.; Busnena, B.A.; El Sayed, K.A.; Kaddoumi, A. Olive-oil-derived oleocanthal enhances β-amyloid clearance as a potential neuroprotective mechanism against Alzheimer's disease: in vitro and in vivo studies. ACS Chem. Neurosci., 2013, 4(6), 973-982.
181. Remya, C.; Dileep, K.V.; Tintu, E.J.; Sadasivan, C. Designing of potent inhibitors of acetylcholinesterase using morin as the starting compound. Frontiers Life Sci., 2012, 6(3-4), 107-117.
182. Campos-Esparza, M.R; Sánchez-Gómez, M.V.; Matute, C. Molecular mechanisms of neuroprotection by two natural antioxidant polyphenols. Cell Calcium, 2009, 45(4), 358-368.